Pregabalin

Back to search

Molecule Structure

Scientific Name

Pregabalin

Description of the Drug

Pregabalin is an anticonvulsant drug used to treat neuropathic pain conditions and fibromyalgia, and for the treatment of partial onset seizures in combination with other anticonvulsants.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00230

Brand Name(s)

Alzain, Axalid, Lecaent, Lyrica, Lyrica cr, Pregabalin, Rewisca

Company Owner(s)

Cipla Ltd, Alkem Laboratories Ltd, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Rising Pharma Holdings Inc, Rubicon Research Private Ltd, Alvogen Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Voltage-gated calcium channel PROTEIN COMPLEX GROUP MODULATOR CHEMBL2363032

Unichem Links

SureChEMBL SCHEMBL8227 SCHEMBL17510367
PharmGKB PA164754814
Human Metabolome Database HMDB0014375
DrugBank DB00230
PubChem: Thomson Pharma 15219358 15171006
PubChem 5486971 25271887
Mcule MCULE-4620415947
Nikkaji J702.547E
BindingDB 50164279
EPA CompTox Dashboard DTXSID1045950
DrugCentral 2255
ChemicalBook CB2251105
Guide to Pharmacology 5484
rxnorm PREGABALIN LYRICA
PubChem: Drugs of the Future 12014780
ChEBI 64356
ZINC ZINC000000005152